Targeting Lymphoma With Benzoxazole Derivatives: Effects on Viability and Protein Expression in Cell Lines
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202402853 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Esma Bilajac und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Bioengineering, Faculty of Engineering and Natural Sciences, International University of Sarajevo, Sarajevo, Bosnia and He…. Hauptthemen laut MEDLINE: Benzoxazoles, Antineoplastic Agents, Lymphoma, Large B-Cell, Diffuse. Die Arbeit nennt 48 Literaturangaben.
Abstract (Originalsprache)
Benzoxazoles possess a wide range of therapeutic activities, including antimicrobial, antitumor, anti‐inflammatory, and other. Using in silico and in vitro approaches, we determined the potential antitumor activity of benzoxazoles synthesized from thymoquinone in diffuse large B‐cell lymphoma (DLBCL) cells. Molecular docking analysis showed strong binding affinities of benzoxazoles toward Akt and nuclear factor kappa B (NF‐κB) protein targets that promote cancer cell proliferation and survival and whose expression is linked to tumorigenesis of activated B‐cell (ABC) and germinal center B‐cell (GCB) DLBCL subtypes. WST‐8 assay showed the highest inhibitory activity of benzoxazole derivative bearing thiophene substituent in both DLBCL models. Western blot analysis indicated the inhibitory activity of selected compounds in HBL‐1 cells, with decreased p ‐NF‐κB and p ‐Akt protein expression, whereas treatment of DHL‐4 cells stimulated the expression of p ‐Akt and p ‐NF‐κB protein levels. These data suggest distinct, cell line‐dependent activities of the substances that potentially act through diverse oncogenic signaling pathways in DLBCL cells and activation of compensatory cell mechanisms that could be an important step for combinatorial treatment approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics and Bioengineering, Faculty of Engineering and Natural Sciences, International University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
- University of Sarajevo-Faculty of Pharmacy, Sarajevo, Bosnia and Herzegovina.
ORCID-Profile: Una Glamočlija
Zitieren
APA
Bilajac, E., Glamočlija, U., Mahmutović, L., Sezer, A., Veljović, E., Špirtović-Halilović, S., Salihović, M., Pazalja, M., Hromić-Jahjefendić, A., & Osmanović, A. (2025). Targeting Lymphoma With Benzoxazole Derivatives: Effects on Viability and Protein Expression in Cell Lines. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202402853
Vancouver
Bilajac E, Glamočlija U, Mahmutović L, Sezer A, Veljović E, Špirtović-Halilović S, et al. Targeting Lymphoma With Benzoxazole Derivatives: Effects on Viability and Protein Expression in Cell Lines. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202402853
BibTeX
@article{Bilajac2025,
author = {Bilajac, Esma and Glamočlija, Una and Mahmutović, Lejla and Sezer, Abas and Veljović, Elma and Špirtović-Halilović, Selma and Salihović, Mirsada and Pazalja, Mirha and Hromić-Jahjefendić, Altijana and Osmanović, Amar},
title = {Targeting Lymphoma With Benzoxazole Derivatives: Effects on Viability and Protein Expression in Cell Lines},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202402853}
}
EUVIMED